MODEST AND REAL OFFERS FOR MESOTHELIOMA
MODEST AND REAL OFFERS FOR MESOTHELIOMA
Physicians presenting clinical information at the Malignant Mesothelioma Conference, taken by the University of Chicago, echoed one and other with a recurring theme–while the past has offered little in the way of advancements in surgical, radiotherapy, and chemotherapy, new active drugs and insights into the biology of mesothelioma are showing real progress, assisting place long-term nihilism that had been associated with the cure of this disease.
Antifolates types, such as premetrexed disodium (Alimta), offer new future for effective treatments, as illustrated by the results of a phase II single agent trial of alimta, in which a confirmed partial response was seen in 14.5PCT (9/62) of advance pleural mesothelioma patients. In this study, 62 chemonaive patients were enrolled with a 5.2:1 M/F ratio, median age of 67 years (range 40-80) stage III/IV disease (31PCT/54PCT), and subhistology of epidermal (74PCT), mixed (14PCT), or sarcamatoid (9PCT) involvement.
[Read the rest of this entry...]
Tags: effective treatments, Malignant Mesothelioma, The median duration of responses, vitamin supplementation